References
Starck SÅ, Rosendahl L. Evaluation and optimization of administered activity, scanning parameters and hydration at (99m)Tc hydroxymethylene diphosphonate adult whole-body bone imaging. Clin Physiol Funct Imaging. 2012;32:431–6.
SmPC Sodium Oxidronate (Technescan HDP®, Mallinckrodt Medical B.V.). In: The Medicines and Healthcare products Regulatory Agency. 2015. http://www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/con1452145923670.pdf. Accessed 21 Jul 2016.
SmPC Medronate (Medronate DRAXIMAGE®, DRAXIMAGE (UK) Limited). In: The Medicines and Healthcare products Regulatory Agency. 2013. http://www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/con1464323651245.pdf. Accessed 21 Jul 2016.
SmPC dicarboxypropane diphosphonate (TECEOS®, CIS BIO INTERNATIONAL). In: L’Agence nationale de sécurité du médicament et des produits de santé. 2012. http://base-donnees-publique.medicaments.gouv.fr/affichageDoc.php?specid=69793728&typedoc=R. Accessed 21 Jul 2016.
ICRP. Radiation dose to patients from radiopharmaceuticals. Addendum 3 to ICRP Publication 53. ICRP Publication 106. Approved by the Commission in October 2007. Ann ICRP. 2008;38:1–197.
Klemenz B, Katzwinkel J, Kaiser KP, Wieler HJ. The influence of differences in hydration on bone-to-soft tissue ratios and image quality in bone scintigraphy. Clin Nucl Med. 1999;24:483–7.
Ferreira S, Cunha L, Fonseca A, Vieira D, Lemos J, Matias M, et al. Study of the influence of patient hydration in bone scintigraphy. Eur J Nucl Med Mol Imaging. 2009;36 Suppl 2:S237.
Author information
Authors and Affiliations
Corresponding author
Additional information
This reply refers to the letter to the editor at http://dx.doi.org/10.1007/s00259-016-3492-4
Rights and permissions
About this article
Cite this article
Van den Wyngaert, T., Paycha, F. Reply to: Starck et al.. Eur J Nucl Med Mol Imaging 43, 2265–2266 (2016). https://doi.org/10.1007/s00259-016-3488-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-016-3488-0